A water-soluble ester of methylprednisolone used for cardiac, allergic, and hypoxic emergencies.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Ceritinib | The risk or severity of hyperglycemia can be increased when Methylprednisolone hemisuccinate is combined with Ceritinib. |
| Aldesleukin | The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Methylprednisolone hemisuccinate. |
| Corticorelin ovine triflutate | The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Methylprednisolone hemisuccinate. |
| Deferasirox | The risk or severity of gastrointestinal ulceration and gastrointestinal irritation can be increased when Methylprednisolone hemisuccinate is combined with Deferasirox. |
| Hyaluronidase (ovine) | The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Methylprednisolone hemisuccinate. |
| Hyaluronidase (human recombinant) | The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Methylprednisolone hemisuccinate. |
| Hyaluronidase | The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Methylprednisolone hemisuccinate. |
| Amphotericin B | The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Amphotericin B. |
| Isoetharine | The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Isoetharine. |
| Norepinephrine | The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Norepinephrine. |
| Phenylpropanolamine | The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Phenylpropanolamine. |
| Epinephrine | The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Epinephrine. |
| Orciprenaline | The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Orciprenaline. |
| Dobutamine | The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Dobutamine. |
| Ritodrine | The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Ritodrine. |
| Bitolterol | The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Bitolterol. |
| Salmeterol | The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Salmeterol. |
| Formoterol | The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Formoterol. |
| Albuterol | The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Salbutamol. |
| Isoprenaline | The therapeutic efficacy of Isoprenaline can be decreased when used in combination with Methylprednisolone hemisuccinate. |
| Arbutamine | The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Arbutamine. |
| Arformoterol | The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Arformoterol. |
| Fenoterol | The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Fenoterol. |
| Pirbuterol | The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Pirbuterol. |
| Ephedra sinica root | The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Ephedra sinica root. |
| Procaterol | The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Procaterol. |
| Clenbuterol | The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Clenbuterol. |
| Celiprolol | The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Celiprolol. |
| Indacaterol | The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Indacaterol. |
| Droxidopa | The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Droxidopa. |
| Protokylol | The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Protokylol. |
| Hexoprenaline | The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Hexoprenaline. |
| Olodaterol | The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Olodaterol. |
| Vilanterol | The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Vilanterol. |
| Doxofylline | The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Doxofylline. |
| Racepinephrine | The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Racepinephrine. |
| Etafedrine | The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Etafedrine. |
| PF-00610355 | The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with PF-00610355. |
| Abediterol | The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Abediterol. |
| Batefenterol | The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Batefenterol. |
| Levosalbutamol | The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Levosalbutamol. |
| Mifepristone | The therapeutic efficacy of Methylprednisolone hemisuccinate can be decreased when used in combination with Mifepristone. |
| Mitotane | The serum concentration of Methylprednisolone hemisuccinate can be decreased when it is combined with Mitotane. |
| Dicoumarol | Methylprednisolone hemisuccinate may increase the anticoagulant activities of Dicoumarol. |
| Phenindione | Methylprednisolone hemisuccinate may increase the anticoagulant activities of Phenindione. |
| Warfarin | Methylprednisolone hemisuccinate may increase the anticoagulant activities of Warfarin. |
| Phenprocoumon | Methylprednisolone hemisuccinate may increase the anticoagulant activities of Phenprocoumon. |
| Acenocoumarol | Methylprednisolone hemisuccinate may increase the anticoagulant activities of Acenocoumarol. |
| 4-hydroxycoumarin | Methylprednisolone hemisuccinate may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Coumarin | Methylprednisolone hemisuccinate may increase the anticoagulant activities of Coumarin. |
| (R)-warfarin | Methylprednisolone hemisuccinate may increase the anticoagulant activities of (R)-warfarin. |
| Ethyl biscoumacetate | Methylprednisolone hemisuccinate may increase the anticoagulant activities of Ethyl biscoumacetate. |
| Fluindione | Methylprednisolone hemisuccinate may increase the anticoagulant activities of Fluindione. |
| Clorindione | Methylprednisolone hemisuccinate may increase the anticoagulant activities of Clorindione. |
| Diphenadione | Methylprednisolone hemisuccinate may increase the anticoagulant activities of Diphenadione. |
| Tioclomarol | Methylprednisolone hemisuccinate may increase the anticoagulant activities of Tioclomarol. |
| (S)-Warfarin | Methylprednisolone hemisuccinate may increase the anticoagulant activities of (S)-Warfarin. |
| Nicorandil | The risk or severity of ulceration can be increased when Methylprednisolone hemisuccinate is combined with Nicorandil. |
| Calcifediol | The therapeutic efficacy of Calcifediol can be decreased when used in combination with Methylprednisolone hemisuccinate. |
| Ergocalciferol | The therapeutic efficacy of Ergocalciferol can be decreased when used in combination with Methylprednisolone hemisuccinate. |
| Dihydrotachysterol | The therapeutic efficacy of Dihydrotachysterol can be decreased when used in combination with Methylprednisolone hemisuccinate. |
| Alfacalcidol | The therapeutic efficacy of Alfacalcidol can be decreased when used in combination with Methylprednisolone hemisuccinate. |
| Seocalcitol | The therapeutic efficacy of Seocalcitol can be decreased when used in combination with Methylprednisolone hemisuccinate. |
| Inecalcitol | The therapeutic efficacy of Inecalcitol can be decreased when used in combination with Methylprednisolone hemisuccinate. |
| Becocalcidiol | The therapeutic efficacy of Becocalcidiol can be decreased when used in combination with Methylprednisolone hemisuccinate. |
| Eldecalcitol | The therapeutic efficacy of Eldecalcitol can be decreased when used in combination with Methylprednisolone hemisuccinate. |
| 1alpha,24S-Dihydroxyvitamin D2 | The therapeutic efficacy of 1alpha,24S-Dihydroxyvitamin D2 can be decreased when used in combination with Methylprednisolone hemisuccinate. |
| Elocalcitol | The therapeutic efficacy of Elocalcitol can be decreased when used in combination with Methylprednisolone hemisuccinate. |
| Maxacalcitol | The therapeutic efficacy of Maxacalcitol can be decreased when used in combination with Methylprednisolone hemisuccinate. |
| Doxercalciferol | The therapeutic efficacy of Doxercalciferol can be decreased when used in combination with Methylprednisolone hemisuccinate. |
| 1alpha-Hydroxyvitamin D5 | The therapeutic efficacy of 1alpha-Hydroxyvitamin D5 can be decreased when used in combination with Methylprednisolone hemisuccinate. |
| Vitamin D | The therapeutic efficacy of Vitamin D can be decreased when used in combination with Methylprednisolone hemisuccinate. |
| Calcitriol | The therapeutic efficacy of Calcitriol can be decreased when used in combination with Methylprednisolone hemisuccinate. |
| Cholecalciferol | The therapeutic efficacy of Cholecalciferol can be decreased when used in combination with Methylprednisolone hemisuccinate. |
| Paricalcitol | The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Methylprednisolone hemisuccinate. |
| Previtamin D(3) | The therapeutic efficacy of Previtamin D(3) can be decreased when used in combination with Methylprednisolone hemisuccinate. |
| Diethylstilbestrol | The serum concentration of Methylprednisolone hemisuccinate can be increased when it is combined with Diethylstilbestrol. |
| Etonogestrel | The serum concentration of Methylprednisolone hemisuccinate can be increased when it is combined with Etonogestrel. |
| Desogestrel | The serum concentration of Methylprednisolone hemisuccinate can be increased when it is combined with Desogestrel. |
| Megestrol acetate | The serum concentration of Methylprednisolone hemisuccinate can be increased when it is combined with Megestrol acetate. |
| Levonorgestrel | The serum concentration of Methylprednisolone hemisuccinate can be increased when it is combined with Levonorgestrel. |
| Progesterone | The serum concentration of Methylprednisolone hemisuccinate can be increased when it is combined with Progesterone. |
| Medroxyprogesterone acetate | The serum concentration of Methylprednisolone hemisuccinate can be increased when it is combined with Medroxyprogesterone acetate. |
| Norethisterone | The serum concentration of Methylprednisolone hemisuccinate can be increased when it is combined with Norethisterone. |
| Estradiol | The serum concentration of Methylprednisolone hemisuccinate can be increased when it is combined with Estradiol. |
| Ethynodiol diacetate | The serum concentration of Methylprednisolone hemisuccinate can be increased when it is combined with Ethynodiol diacetate. |
| Norgestimate | The serum concentration of Methylprednisolone hemisuccinate can be increased when it is combined with Norgestimate. |
| Ethinylestradiol | The serum concentration of Methylprednisolone hemisuccinate can be increased when it is combined with Ethinylestradiol. |
| Mestranol | The serum concentration of Methylprednisolone hemisuccinate can be increased when it is combined with Mestranol. |
| Drospirenone | The serum concentration of Methylprednisolone hemisuccinate can be increased when it is combined with Drospirenone. |
| Estrone sulfate | The serum concentration of Methylprednisolone hemisuccinate can be increased when it is combined with Estrone sulfate. |
| Octylphenoxy polyethoxyethanol | The serum concentration of Methylprednisolone hemisuccinate can be increased when it is combined with Octylphenoxy polyethoxyethanol. |
| Cyproterone acetate | The serum concentration of Methylprednisolone hemisuccinate can be increased when it is combined with Cyproterone acetate. |
| Norelgestromin | The serum concentration of Methylprednisolone hemisuccinate can be increased when it is combined with Norelgestromin. |
| Gestodene | The serum concentration of Methylprednisolone hemisuccinate can be increased when it is combined with Gestodene. |
| Hydroxyprogesterone caproate | The serum concentration of Methylprednisolone hemisuccinate can be increased when it is combined with Hydroxyprogesterone caproate. |
| Norethynodrel | The serum concentration of Methylprednisolone hemisuccinate can be increased when it is combined with Norethynodrel. |
| Norgestrel | The serum concentration of Methylprednisolone hemisuccinate can be increased when it is combined with Norgestrel. |
| Cloprostenol | The serum concentration of Methylprednisolone hemisuccinate can be increased when it is combined with Cloprostenol. |
| Gestrinone | The serum concentration of Methylprednisolone hemisuccinate can be increased when it is combined with Gestrinone. |